Starton Therapeutics
startontx.com
Actively hiring
Financial Services
Biotechnology
Health Care
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
1
North Bay Capital
Momentum
0/100
no fresh signals
Backed byfrom the funds' portfolios and accelerator catalogs
North Bay Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
"We are committed to creating the future of oncology by developing innovative therapies inducing autophagy to address unmet medical needs".
ACEA Therapeutics is a clinical stage pharmaceutical company with a diverse product portfolio to address unmet medical needs in cancer…
Himuka AM Pharma develops drug candidates derived from adrenomedullin (AM), a bioactive peptide originally discovered at the University of…
Heqet Therapeutics Heqet Therapeutics develops first-in-class non-coding RNA-based compounds to address highly unmet medical needs in acute…
Technology. Dreamfold develops generative AI models to unlock more effective therapies for cancer, immune diseases, and other serious…
Cogent Biosciences is a biotechnology company focused on developing novel precision therapies to treat a broad range of patients with unmet…
Overview
Determined to address unmet medical needs The FDA defines unmet medical need for cancer as a serious condition that is not adequately treated by current therapies. This could include conditions that are rare, have few treatment options, significant tolerability issues, or have poor survival rates.